Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Bruce W. Robinson, MD, PhD
Dr. Bruce W. Robinson seeks to identify novel neo-antigens in lung cancer and mesothelioma in order to… -
CRI Funded Scientist
William H. Hudson, PhD
Dr. William H. Hudson is adapting T cell receptor (TCR) sequencing technology for use on preserved tissue… -
CRI Funded Scientist
Rita Leonor Fior, PhD
Dr. Rita Leonor Fior is utilizing a novel “zAvatar” model to improve our understanding of cancer-immune interactions… -
CRI Funded Scientist
Linyu Sun, PhD
Checkpoint blockade immunotherapy has achieved durable responses in several solid tumor types by reinvigorating the anti-tumor function… -
CRI Funded Scientist
Rebecca B. Delconte, PhD
Despite advances in treatment and early detection, cancer is still one of the major causes of death… -
CRI Funded Scientist
Barsha Dash, PhD
T cells of the immune system have the remarkable ability to expand in numbers and to kill… -
CRI Funded Scientist
Stanislav Dikiy, PhD
Our bodies harbor trillions of microbes throughout the gastrointestinal tract, which are collectively referred to as the… -
CRI Funded Scientist
Chiara Falcomatà, PhD
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease that lacks efficient therapies. While immunotherapies have been shown… -
CRI Funded Scientist
Nicholas Martin, PhD
Dr. Martin’s research focuses on how immune cells migrate through our tissues. Neutrophils are immune cells that…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.